
Jennifer Daly
Articles
-
May 8, 2024 |
onlinelibrary.wiley.com | Katherine Ling |Guillaume Ricaud |Jennifer Daly |Leon F. Stankowski
Background N-(-9 acridinyl)-b-alanine hydrochloride (S-300) is the main byproduct of red blood cell (RBC) amustaline/glutathione(GSH) pathogen reduction, currently undergoing phase III US clinical trials following successful European studies(1–3).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →